Literature DB >> 11464908

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.

K Ejeskär1, R M Sjöberg, F Abel, P Kogner, P F Ambros, T Martinsson.   

Abstract

BACKGROUND: A common genetic feature of neuroblastomas, which is also an important prognostic factor, is deletion of chromosome region 1p. The deletion of 1p often involves a deletion of varying size, with a consensus region within the most distal bands 1p36.2-3. The neuroblastoma SRO (shortest region of overlap of (deletions) presented earlier by our group was defined distally by the cluster of loci D1S80/ D1Z2/CDC2L1 and proximally by loci D1S244, i.e., approximately 25 cM. The 1p deletions are, however, not restricted to neuroblastoma tumours. In fact, a large spectrum of tumour types display deletions to varying degrees of 1p. PROCEDURE: We have exploited the possibility of using deletions of other tumour types, preferentially that of germ cell tumours, and combining the deletions with that of the neuroblastoma SRO. Also in germ cell tumours, distal 1p-deletions have been shown to have prognostic significance.
RESULTS: We found in our germ cell tumours a SRO ranging from D1S508 to D1S200. Interestingly, this region only partially overlapped (approximately 5 cm) with our neuroblastoma SRO in region D1S508 to D1S244. We have thus focused on analysing this smaller region in the search for genes involved in the genesis of different cancers. We have performed radiation hybrid mapping of a large number of markers, STSs, ESTs, and others known to reside in 1p. We have also initiated the development of a BAC contig of the region. FISH, and fibre-FISH mapping of BACs were also performed.
CONCLUSIONS: The data presented here constitute an ongoing work with the aim of identifying and cloning gene(s) important for development of germ cell tumours, neuroblastomas, and possibly other tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464908     DOI: 10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

1.  High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival.

Authors:  Susanne Fransson; Katarina Ejeskär
Journal:  Med Oncol       Date:  2013-09-12       Impact factor: 3.064

2.  KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.

Authors:  Arasambattu K Munirajan; Kiyohiro Ando; Akira Mukai; Masato Takahashi; Yusuke Suenaga; Miki Ohira; Tadayuki Koda; Toru Hirota; Toshinori Ozaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

3.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

4.  Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.

Authors:  F Abel; R-M Sjöberg; K Ejeskär; C Krona; T Martinsson
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

5.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

6.  A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.

Authors:  Helena Carén; Katarina Ejeskär; Susanne Fransson; Luke Hesson; Farida Latif; Rose-Marie Sjöberg; Cecilia Krona; Tommy Martinsson
Journal:  Mol Cancer       Date:  2005-03-01       Impact factor: 27.401

7.  Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.

Authors:  D Astuti; M Morris; C Krona; F Abel; D Gentle; T Martinsson; P Kogner; H P H Neumann; R Voutilainen; C Eng; P Rustin; F Latif; E R Maher
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

8.  Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours.

Authors:  H Carén; S Fransson; K Ejeskär; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

9.  High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Authors:  Helena Carén; Jennie Erichsen; Linda Olsson; Charlotta Enerbäck; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  BMC Genomics       Date:  2008-07-29       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.